SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sandu Pharmaceutical - Quaterly Results

07 Feb 2026 Evaluate
The company's total revenue for the quarter ended December 2025 saw a slight change in the total revenue, having registered a total revenue of Rs. 187.61 millions.Handsome Net Profit growth of 75.68% reported above the corresponding previous quarter figure of Rs. 9.75 millions to Rs. 5.55 millions.Operating profit surged to 10.55 millions from the corresponding previous quarter of 10.15 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 187.61 183.73 2.11 530.81 531.23 -0.08 671.92 672.81 -0.13
Other Income 0.14 0.25 -44.00 0.80 0.99 -19.19 1.68 4.21 -60.10
PBIDT 10.55 10.15 3.94 25.08 24.12 3.98 29.30 27.18 7.80
Interest 0.34 0.27 25.93 0.87 0.76 14.47 1.03 0.63 63.49
PBDT 10.21 9.88 3.34 24.21 23.36 3.64 28.27 26.55 6.48
Depreciation 1.66 1.90 -12.63 5.13 5.23 -1.91 6.71 5.83 15.09
PBT 8.55 7.98 7.14 19.08 18.13 5.24 21.56 20.72 4.05
TAX -1.20 2.43 -149.38 1.85 5.92 -68.75 6.07 6.12 -0.82
Deferred Tax -0.71 0.14 -607.14 -0.60 0.77 -177.92 0.18 0.25 -28.00
PAT 9.75 5.55 75.68 17.23 12.21 41.11 15.49 14.60 6.10
Equity 96.61 96.61 0.00 96.61 96.61 0.00 96.61 96.61 0.00
PBIDTM(%) 5.62 5.52 1.79 4.72 4.54 4.06 4.36 4.04 7.94

Sandu Pharmaceutical Share Price

38.45 0.50 (1.32%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×